Capital Flow Monitor · Sponsors · CIK 1980223

NexPoint Life Sciences II DST

300 CRESCENT COURT, DALLAS, TX, 75201 · 833-697-6246

Other Real Estate · Other· inc. DELAWARE true 2023

Fit score

53

  • pct_sold>=95+26
  • placement_agent+12
  • investors 61-150+6
  • filed<=10mo+5
  • people+4

Offering

$40.5M

Sold

$40.5M

% sold

100.0%

Investors

112

Min investment

$100K

Exemption

506(c)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-11-20 D/A ·current 506(c) $40.5M $40.5M 100.0% 112 EDGAR ↗
2025-11-07 D/A 506(c) $40.5M $39.6M 97.7% 109 EDGAR ↗
2025-09-09 D/A 506(c) $40.5M $37.0M 91.4% 105 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed.

  • N/A NexPoint Real Estate Advisors IV, L.P. — Executive Officer, Dallas, TX
  • Matthew Goetz — Executive Officer, Dallas, TX
  • N/A NREA Life Sciences II, LLC — Executive Officer, Dallas, TX
  • N/A NREA LS II Investment Co, LLC — Executive Officer, Dallas, TX
  • Matt McGraner — Executive Officer, Dallad, TX

Placement agents

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.